Boston, MA – October 2, 2018 – Kyruus, a leader in provider search and scheduling solutions for health systems, today announced that Stephen Kahane, M.D., M.S., has joined its Board of Directors. Dr. Kahane, a senior executive at athenahealth since 2011, is an accomplished healthcare technology executive with a track record of driving innovation, company growth, and value creation. He will draw on his deep industry knowledge and experience to support Kyruus as it continues its rapid growth trajectory and brings additional industry-defining solutions to market.

Kahane brings more than 30 years of healthcare technology industry experience to his position as a Kyruus Board Director. Having spent the last eight years in leadership positions at athenahealth, he has been instrumental in accelerating the adoption of its solutions among physician practices and health systems. 

“Kyruus has developed a platform that addresses a profound gap in healthcare, pioneering the patient access category with a solution that improves both the patient and provider experience,” said Dr. Kahane. “I’m eager to help the Kyruus team further shape this category and expand the company’s reach across the nation’s leading health systems.” 

Previously, Kahane served as CEO of AMICAS, a publicly-traded imaging and information management company. He also served as CEO at two EHR and practice management companies: VitalWorks, which Cerner acquired in 2005, and Datamedic, which InfoCure acquired in 1999. Dr. Kahane earned his Doctor of Medicine and Bachelor’s degrees from Emory University and completed his clinical training in internal medicine at Johns Hopkins, where he also earned a Master’s degree in Computer Science.

“I’m very excited to invite Stephen onto our Board of Directors and am looking forward to partnering with a fellow physician-turned-entrepreneur who brings a unique combination of clinical, operational, and entrepreneurial expertise to our Board,” said Graham Gardner, M.D., MBA, CEO of Kyruus. “We look forward to leveraging his insights to help drive our continued commercial momentum and further shape the future of this industry.”